Summary
Synopsys, Inc. (SNPS) reported its annual results for the fiscal year ended October 31, 2004. The company faced a challenging business environment within the semiconductor industry, which experienced a significant downturn followed by a slower-than-expected recovery. This impacted Synopsys' order and revenue performance, particularly in the latter half of the fiscal year. A key strategic shift was made in Q4 FY2004 towards an almost entirely time-based licensing model, which, while meeting customer needs for cash conservation, reduced current-period revenue recognized upfront. Despite the revenue decline of 7% to $1.09 billion compared to fiscal 2003, Synopsys continued to invest in its product platforms, including enhancements to the Galaxy Design and Discovery Verification platforms. The company also pursued strategic acquisitions to bolster its IP portfolio and design for manufacturing capabilities. Net income decreased to $74.3 million from $149.7 million in the prior year, reflecting lower revenue and increased amortization costs from acquisitions. The company maintained a strong balance sheet with $579 million in cash, cash equivalents, and short-term investments, and actively repurchased shares under its stock repurchase program.
Key Highlights
- 1Revenue for fiscal year 2004 decreased by 7% to $1.09 billion compared to $1.18 billion in fiscal 2003, driven by a challenging semiconductor market and a shift to a more ratable licensing model.
- 2Net income declined to $74.3 million from $149.7 million in fiscal 2003, impacted by lower revenues and increased amortization expenses from acquisitions.
- 3The company completed several acquisitions in fiscal 2004, including Accelerant Networks, Inc. and Cascade Semiconductors, Inc., to enhance its IP and design for manufacturing offerings.
- 4Synopsys shifted its target license mix in Q4 FY2004 to be almost entirely time-based licenses, a move expected to reduce revenue seasonality but negatively impact short-term revenue recognition.
- 5The company repurchased approximately 16.9 million shares of common stock in fiscal 2004 for $423 million and renewed its stock repurchase program.
- 6Despite revenue pressures, Synopsys continued R&D investment, with R&D expenses remaining stable at $285.3 million for fiscal 2004.
- 7The company ended fiscal year 2004 with a strong liquidity position, reporting $579 million in cash, cash equivalents, and short-term investments.